tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Salim Syed, 120 are a BUY (75.47%), 39 are a HOLD (24.53%).
Analyst Salim Syed, currently employed at MIZUHO, carries an average stock price target met ratio of 57.48% that have a potential upside of 41.18% achieved within 237 days.
Salim Syed’s has documented 305 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CYTK, Cytokinetics at 29-May-2025.
Analyst best performing recommendations are on NKTX (NKARTA ).
The best stock recommendation documented was for NKTX (NKARTA ) at 11/16/2023. The price target of $9 was fulfilled within 53 days with a profit of $6.64 (281.36%) receiving and performance score of 53.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$328
$39.82 (13.82%)
$329
17 days ago
(16-May-2025)
1/3 (33.33%)
$55.59 (20.41%)
54
Hold
$280
$-8.18 (-2.84%)
$235
26 days ago
(07-May-2025)
17/21 (80.95%)
$4.16 (1.51%)
406
Buy
$320
$31.82 (11.04%)
$324
1 months ago
(02-May-2025)
12/16 (75%)
$38.78 (13.79%)
75
Hold
$330
$41.82 (14.51%)
$303
1 months 24 days ago
(09-Apr-2025)
13/14 (92.86%)
$38.91 (13.37%)
730
Sell
$294
$5.82 (2.02%)
$275
2 months 28 days ago
(05-Mar-2025)
4/5 (80%)
$-18.19 (-5.83%)
89
Which stock is Salim Syed is most bullish on?
Which stock is Salim Syed is most reserved on?
What Year was the first public recommendation made by Salim Syed?
